Phase transitions in human IgG solutions.

Protein condensations, such as crystallization, liquid-liquid phase separation, aggregation, and gelation, have been observed in concentrated antibody solutions under various solution conditions. While most IgG antibodies are quite soluble, a few outliers can undergo condensation under physiological conditions. Condensation of IgGs can cause serious consequences in some human diseases and in biopharmaceutical formulations. The phase transitions underlying protein condensations in concentrated IgG solutions is also of fundamental interest for the understanding of the phase behavior of non-spherical protein molecules. Due to the high solubility of generic IgGs, the phase behavior of IgG solutions has not yet been well studied. In this work, we present an experimental approach to study IgG solutions in which the phase transitions are hidden below the freezing point of the solution. Using this method, we have investigated liquid-liquid phase separation of six human myeloma IgGs and two recombinant pharmaceutical human IgGs. We have also studied the relation between crystallization and liquid-liquid phase separation of two human cryoglobulin IgGs. Our experimental results reveal several important features of the generic phase behavior of IgG solutions: (1) the shape of the coexistence curve is similar for all IgGs but quite different from that of quasi-spherical proteins; (2) all IgGs have critical points located at roughly the same protein concentration at ~100 mg/ml while their critical temperatures vary significantly; and (3) the liquid-liquid phase separation in IgG solutions is metastable with respect to crystallization. These features of phase behavior of IgG solutions reflect the fact that all IgGs have nearly identical molecular geometry but quite diverse net inter-protein interaction energies. This work provides a foundation for further experimental and theoretical studies of the phase behavior of generic IgGs as well as outliers with large propensity to condense. The investigation of the phase diagram of IgG solutions is of great importance for the understanding of immunoglobulin deposition diseases as well as for the understanding of the colloidal stability of IgG pharmaceutical formulations.

[1]  Abraham M Lenhoff,et al.  Interactions and phase behavior of a monoclonal antibody , 2011, Biotechnology progress.

[2]  H. Lekkerkerker,et al.  Insights into phase transition kinetics from colloid science , 2002, Nature.

[3]  S. Salmon,et al.  A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.

[4]  P. Schurtenberger,et al.  Phase separation in binary eye lens protein mixtures , 2011 .

[5]  Neer Asherie,et al.  Liquid-solid transition in nuclei of protein crystals , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Benedek,et al.  Effect of polyethylene glycol on the liquid–liquid phase transition in aqueous protein solutions , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Bergenholtz,et al.  Depletion interactions in model microemulsions. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[8]  N. Munshi,et al.  Pathological crystallization of human immunoglobulins , 2012, Proceedings of the National Academy of Sciences.

[9]  G. Benedek,et al.  Phase separation in solutions of monoclonal antibodies and the effect of human serum albumin , 2011, Proceedings of the National Academy of Sciences.

[10]  D. Blankschtein,et al.  Liquid-liquid phase separation of aqueous lysozyme solutions: effects of pH and salt identity , 1990 .

[11]  S. Wereley,et al.  soft matter , 2019, Science.

[12]  P. Vekilov,et al.  Control of protein crystal nucleation around the metastable liquid-liquid phase boundary. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Faraday Discuss , 1985 .

[14]  D. Frenkel,et al.  Phase behavior of a lattice protein model , 2003 .

[15]  G. Benedek,et al.  Oligomerization and phase transitions in aqueous solutions of native and truncated human beta B1-crystallin. , 2005, Biochemistry.

[16]  B. Grimbacher,et al.  Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency , 2010, European journal of medical research.

[17]  Bruce D Mason,et al.  Liquid-liquid phase separation of a monoclonal antibody and nonmonotonic influence of Hofmeister anions. , 2010, Biophysical journal.

[18]  Marcel Ottens,et al.  Phase behavior of an intact monoclonal antibody. , 2007, Biophysical journal.

[19]  P. Schurtenberger,et al.  Binary liquid phase separation and critical phenomena in a protein/water solution. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Roland Roth,et al.  The role of cluster formation and metastable liquid - Liquid phase separation in protein crystallization , 2012 .

[21]  A. Vrij,et al.  Polymers at Interfaces and the Interactions in Colloidal Dispersions , 1976 .

[22]  R. Rosenfeld Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[23]  James D. Gunton,et al.  Protein Condensation: Kinetic Pathways to Crystallization and Disease , 2007 .

[24]  Fumio Oosawa,et al.  On Interaction between Two Bodies Immersed in a Solution of Macromolecules , 1954 .

[25]  Bruce D Mason,et al.  Opalescence of an IgG2 monoclonal antibody solution as it relates to liquid-liquid phase separation. , 2011, Journal of pharmaceutical sciences.

[26]  David Wild,et al.  The immunoassay handbook : theory and applications of ligand binding, ELISA and related techniques , 2013 .

[27]  M. Basan,et al.  Altered phase diagram due to a single point mutation in human γD-crystallin , 2007, Proceedings of the National Academy of Sciences.

[28]  A. Kay Practical Immunology , 1977 .

[29]  R. Pecora Dynamic Light Scattering , 1985 .

[30]  G. Benedek,et al.  Aeolotopic interactions of globular proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  N. Ferté,et al.  Exploring bovine pancreatic trypsin inhibitor phase transitions. , 2006, The journal of physical chemistry. B.

[32]  Hollis Lau,et al.  The use of native cation‐exchange chromatography to study aggregation and phase separation of monoclonal antibodies , 2010, Protein science : a publication of the Protein Society.

[33]  J. King,et al.  Crystal cataracts: Human genetic cataract caused by protein crystallization , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Light scattering and phase behavior of lysozyme-poly(ethylene glycol) mixtures. , 2005, Physical review letters.

[35]  J. Tamburini,et al.  Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature , 2013, Leukemia & lymphoma.

[36]  Igor Polikarpov,et al.  Average protein density is a molecular‐weight‐dependent function , 2004, Protein science : a publication of the Protein Society.

[37]  B. Berne,et al.  Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics , 1976 .

[38]  R. Bhat,et al.  Steric exclusion is the principal source of the preferential hydration of proteins in the presence of polyethylene glycols , 1992, Protein science : a publication of the Protein Society.

[39]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[40]  F. Young Biochemistry , 1955, The Indian Medical Gazette.

[41]  O. Annunziata,et al.  Comparison between protein-polyethylene glycol (PEG) interactions and the effect of PEG on protein-protein interactions using the liquid-liquid phase transition. , 2007, The journal of physical chemistry. B.

[42]  D. Frenkel,et al.  Enhancement of protein crystal nucleation by critical density fluctuations. , 1997, Science.

[43]  C. Zukoski,et al.  Protein interactions and phase behavior: Sensitivity to the form of the pair potential , 1999 .

[44]  G. Benedek,et al.  Observation of liquid–liquid phase separation for eye lens γS-crystallin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Neer Asherie,et al.  Decrease in protein solubility and cataract formation caused by the Pro23 to Thr mutation in human gamma D-crystallin. , 2005, Biochemistry.

[46]  E. Kaler,et al.  Protein phase behavior in aqueous solutions: crystallization, liquid-liquid phase separation, gels, and aggregates. , 2008, Biophysical journal.

[47]  D. Wild The Immunoassay Handbook , 2001 .

[48]  T. Osslund,et al.  Crystallization and liquid‐liquid phase separation of monoclonal antibodies and fc‐fusion proteins: Screening results , 2011, Biotechnology progress.

[49]  Limei Xu,et al.  Homogeneous crystal nucleation near a metastable fluid-fluid phase transition. , 2012, Physical review letters.

[50]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[51]  Franz Rosenberger,et al.  Liquid-Liquid Phase Separation in Supersaturated Lysozyme Solutions and Associated Precipitate Formation/Crystallization , 1997 .

[52]  Paul S. Russo,et al.  Phase Transitions in the Assembly of MultiValent Signaling Proteins , 2016 .

[53]  G. Benedek,et al.  Monte Carlo study of phase separation in aqueous protein solutions , 1996 .

[54]  R. Nagel,et al.  Liquid–liquid separation in solutions of normal and sickle cell hemoglobin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  W. Deen,et al.  Ultrastructural model for size selectivity in glomerular filtration. , 1999, American journal of physiology. Renal physiology.

[56]  F. Dorsey,et al.  The effect of aging on human serum immunoglobulin concentrations. , 1970, Journal of immunology.

[57]  Fumio Oosawa,et al.  Interaction between particles suspended in solutions of macromolecules , 1958 .

[58]  Kiichi Fukui,et al.  Phase Separation of an IgG1 Antibody Solution under a Low Ionic Strength Condition , 2010, Pharmaceutical Research.

[59]  Z. Hall Cancer , 1906, The Hospital.